Covetrus®, a global player in animal-health technology and services, announced the appointment of Ajoy Karna as executive vice president and chief financial officer. Karna succeeds Matthew Foulston, who announced previously his retirement from the company. Karna joins Covetrus from Sysco Corporation, where during his 10 years with the firm, he held a number of senior finance and strategic leadership roles, including senior vice president of finance for international, and the firm’s North American foodservice distribution businesses.
Sebastian Rönnlund from Netlight has been appointed interim CTO at Encare. Sebastian joins Encare to strengthen the company in connection with the acceleration of international expansion to establish an even more efficient and modern development organization. Encare expands its team with a new CTO to increase the turnover in the product organization.
Two in three Aussies will develop skin cancer by the age of 70 – but TAL research reveals most Aussies are unaware of just how common skin cancer is, with more than 7 in 10 (72%) believing the rate of diagnosis is lower. A lot of sun exposure is ‘incidental’, taking place during those moments when we’re not really conscious of being exposed to the sun.
The Ellie Sparkle’s Show surveyed 1,000 kids aged 5-8 across the US to find out what they dream of becoming when they grow up, how they want to work and why they want to do it. Since 81% of parents in the US said they regularly talk to their children about their career aspirations, the survey commissioned by the children’s entertainment show also asked 1,000 US parents what they dream of for their children's future job roles.
A.H. Beard, the 123 year old Australian made and owned bedding company has launched its brand campaign showcasing the value of Premium Sleep. A concept of sleep that rejects the common misconception that ‘sleep is for the weak’, but rather a vital act that replenishes, repairs, and restores. Created by Head and Heart and Premium, shot at award-winning architectural home Dovecote, the campaign invites viewers to rethink how we view sleep.
With the mission to contribute to a cure for paralysis, RoboFit is the culmination of a 10 year journey for husband and wife duo Maryanne Harris and Daniel Hillyer - offering Australia’s first neuro-responsive exoskeleton and opening Australia’s first robot powered therapy centre. Using cutting-edge tech to redefine rehabilitation by combining exercise physiology and physiotherapy, Cyberdyne’s tech changed founder Daniel’s life, restoring motor and sensory function once thought to be lost forever and proving that you should never say never.
Planting a new seed in the medicinal cannabis industry, Polln is a comprehensive and holistic online telehealth company, delivering treatment to patients living with chronic conditions in the comfort of their homes. With Polln, patients can speak to some of Australia’s most experienced cannabis clinicians who can then, where suitable, prescribe medicinal cannabis.
Nectar Brands announced the launch of their digital health solutions which are set to improve patient care and access to digital health services in Australia. The company has rolled out a range of end-to-end solutions through their portfolio of brands including Cultiva (medicinal cannabis flower brand) and Polln (online telehealth clinic). Planting a new seed for the future, Nectar Brands are providing top quality personalised care, in a virtual environment.
Biomedical and electrical engineers at UNSW Sydney have developed a new way to measure neural activity using light – rather than electricity – which could lead to a complete reimagining of medical tech like nerve-operated prosthetics and brain-machine interfaces. Prof François Ladouceur, with the School of Electrical Engineering and Telecommunications at UNSW, says the multi-disciplinary team has just demonstrated in the lab what it proved theoretically shortly before the pandemic: that sensors built using liquid crystal and integrated optics technologies – dubbed ‘optrodes’ – can register nerve impulses in a living animal body.
Centivax, a broad-spectrum vaccine platform technology company, announced $10m in seed financing in a syndicate co-led by NFX and the Global Health Investment Corporation (GHIC). The funding will be used to initiate manufacturing of its broad-spectrum vaccine program in influenza for first-in-human clinical trials, and continue development of its vaccine platform tech in other critical areas of unmet global health need, including COVID-19 and HIV/AIDS.